Manufacturers have come under scrutiny for their marketing tactics amid the national opioid overdose epidemic, which was tied to about 50,000 deaths in 2017.
Novoheart uses stem cell, bioengineering and AI to produce the "heart in-a-jar," which can be used to test the efficacy of drugs.”
Jim Rowan, Dyson’s CEO, said the move to Singapore was not due to tax or fears of Brexit, but to the shift in the importance of the region to the company.
"The key to electrifying vehicles in the future will be batteries. In order for Japan to survive this era of profound change with no natural resources, we must develop competitive batteries and establish systems for a stable supply," Akio Toyoda...
Former Nissan chairman now in third month of Tokyo detention.
Deal is Bridgestone’s biggest ever acquisition in Europe.
“We need to have the agility to adapt to a range of factors, including global economic conditions.”
Electric-car maker says it eked out a profit in fourth quarter.